Writing from thirty years in precision diagnostics: from biomarker validation to liver longevity and national‑scale precision medicine programmes, including ideas behind my book Precision Diagnostics: A Founder’s Journey.
Published on MedEdgeMEA on May 31th Introduction: A New Frontier for Liver Transplantation Precision medicine has transformed fields like oncology and cardiology, but liver transplantation has been left behind. Despite being a domain where decisions often mean life or death, the field still relies on outdated clinical scoring systems. But this is changing. The tools…
This reflection was heavily reliant on sourcing information and testing arguments with my favourite AI agent: Perplexity.AI. The ideas, interpretations, and conclusions are mine. The estimates on impact (e.g., life-years gained, cost savings) are approximations and should be taken with a grain of salt. Finally, I did my best to make sure no ‘source hallucinations’…
this was published as an article on Linkedin and copied here. As an entrepreneur in precision medicine, I keep worrying about where can my AI-powered, precision liver medicine agenda truly find a home? It’s not just a strategic exercise-though the availability of investment, the spirit of innovation in medical communities, regulatory frameworks, the appetite for…
I’ve followed Abu Dhabi Health Week from afar, and I find myself still thinking about the energy and optimism that surrounded the conversations on precision medicine and longevity. There’s something exhilarating about seeing the future of healthcare come to be—AI, genomics, new therapeutics, all promising to help us live longer, healthier lives. It’s hard not…
This post was motivated by my experiences advising startups, participating in acceleration programs, and working with academic research groups. Over the years, I’ve seen the challenges of translating biomarker discoveries into impactful diagnostic products, and I hope to share some lessons learned to help others navigate this complex but rewarding journey. Note on AI usage:…
I presented the development of HepatoPredict and our experience of translating discoveries on biomarkers into clinically relevant ready to use products at the meeting Precision Medicine in Oncology In Porto. Thank you Nuno value for the invitation.